Centene Résultats passés
Passé contrôle des critères 5/6
Centene a connu une croissance annuelle moyenne de ses bénéfices de 17.3%, tandis que le secteur Healthcare a vu ses bénéfices augmenter de en hausse à 5.3% par an. Les revenus ont augmenté de en hausse à un taux moyen de 13.3% par an. Le rendement des capitaux propres de Centene est 11.1% et ses marges nettes sont de 2.1%.
Informations clés
17.3%
Taux de croissance des bénéfices
14.4%
Taux de croissance du BPA
| Healthcare Croissance de l'industrie | 8.5% |
| Taux de croissance des recettes | 13.3% |
| Rendement des fonds propres | 11.1% |
| Marge nette | 2.1% |
| Dernière mise à jour des bénéfices | 30 Sep 2024 |
Mises à jour récentes des performances passées
Recent updates
Centene: Should Have Followed My Original Thesis, But A Buy For Q3 2024
Oct 22Centene Corporation (NYSE:CNC) Screens Well But There Might Be A Catch
Oct 14
Should You Be Adding Centene (NYSE:CNC) To Your Watchlist Today?
Sep 26Centene (NYSE:CNC) Has Some Way To Go To Become A Multi-Bagger
Sep 08Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly
Aug 20Centene Corporation: Strategic Market Position Amid Favorable Trends, Buy
Aug 20Centene (NYSE:CNC) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Aug 02Here's Why We Think Centene (NYSE:CNC) Is Well Worth Watching
Jun 22A Piece Of The Puzzle Missing From Centene Corporation's (NYSE:CNC) Share Price
Jun 04Returns At Centene (NYSE:CNC) Appear To Be Weighed Down
May 14These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well
Apr 26Centene Corporation Still An Opportunity With An A-Grade Valuation
Mar 31If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Mar 15Market Still Lacking Some Conviction On Centene Corporation (NYSE:CNC)
Feb 08Centene: Stay Defensive Amid Economic Uncertainty With This Low-Beta Bargain
Jan 22Is Centene (NYSE:CNC) Using Too Much Debt?
Jan 21Centene: Overlooked Healthcare Giant
Nov 21Does Centene (NYSE:CNC) Deserve A Spot On Your Watchlist?
Nov 10Centene: Solid Performance With Positive Outlook, But Limited Upside Potential
Oct 26These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well
Oct 22Decoding Centene: Why I Think It's Undervalued
Oct 10If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Jul 31Centene: Results Impress But Buyers Aren't Swarming Yet
Jul 27Centene (NYSE:CNC) Has A Pretty Healthy Balance Sheet
Jul 12Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly
Apr 10Centene Non-GAAP EPS of $0.86 beats by $0.02, revenue of $35.56B beats by $190M
Feb 07With EPS Growth And More, Centene (NYSE:CNC) Makes An Interesting Case
Jan 27Centene (NYSE:CNC) Seems To Use Debt Rather Sparingly
Dec 27Centene: Once Again, With Quality, Now A 'Buy'
Dec 23Centene appoints new leadership; Ken Fasola President of Centene, Dave Thomas CEO of Medicaid
Dec 14An Intrinsic Calculation For Centene Corporation (NYSE:CNC) Suggests It's 50% Undervalued
Nov 11Ventilation des recettes et des dépenses
Comment Centene gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Sep 24 | 146,204 | 3,067 | 12,507 | 0 |
| 30 Jun 24 | 144,064 | 2,823 | 12,455 | 0 |
| 31 Mar 24 | 142,800 | 2,735 | 12,573 | 0 |
| 31 Dec 23 | 141,266 | 2,702 | 12,407 | 0 |
| 30 Sep 23 | 139,364 | 2,444 | 12,130 | 0 |
| 30 Jun 23 | 138,111 | 2,713 | 11,934 | 0 |
| 31 Mar 23 | 136,941 | 1,483 | 11,704 | 0 |
| 31 Dec 22 | 135,999 | 1,202 | 11,366 | 0 |
| 30 Sep 22 | 132,756 | 2,014 | 10,892 | 0 |
| 30 Jun 22 | 129,228 | 1,860 | 10,562 | 0 |
| 31 Mar 22 | 124,181 | 1,497 | 9,888 | 0 |
| 31 Dec 21 | 118,573 | 1,347 | 9,376 | 0 |
| 30 Sep 21 | 114,130 | 736 | 9,657 | 0 |
| 30 Jun 21 | 111,284 | 720 | 9,995 | 0 |
| 31 Mar 21 | 108,158 | 2,461 | 10,461 | 0 |
| 31 Dec 20 | 104,280 | 1,808 | 10,276 | 0 |
| 30 Sep 20 | 95,764 | 2,029 | 9,529 | 0 |
| 30 Jun 20 | 86,523 | 1,556 | 8,301 | 0 |
| 31 Mar 20 | 78,105 | 845 | 7,290 | 0 |
| 31 Dec 19 | 70,807 | 1,321 | 6,448 | 0 |
| 30 Sep 19 | 68,385 | 1,353 | 6,472 | 0 |
| 30 Jun 19 | 65,507 | 1,277 | 6,591 | 0 |
| 31 Mar 19 | 61,028 | 1,082 | 6,457 | 0 |
| 31 Dec 18 | 56,688 | 900 | 6,331 | 0 |
| 30 Sep 18 | 52,618 | 889 | 5,795 | 0 |
| 30 Jun 18 | 48,655 | 1,075 | 5,105 | 0 |
| 31 Mar 18 | 47,201 | 1,029 | 4,797 | 0 |
| 31 Dec 17 | 45,810 | 828 | 4,370 | 0 |
| 30 Sep 17 | 44,870 | 853 | 4,267 | 0 |
| 30 Jun 17 | 43,646 | 796 | 4,303 | 0 |
| 31 Mar 17 | 42,468 | 713 | 4,246 | 0 |
| 31 Dec 16 | 37,693 | 562 | 3,900 | 0 |
| 30 Sep 16 | 32,839 | 416 | 3,284 | 0 |
| 30 Jun 16 | 28,062 | 360 | 2,719 | 0 |
| 31 Mar 16 | 22,948 | 277 | 2,152 | 0 |
| 31 Dec 15 | 21,292 | 356 | 1,990 | 0 |
| 30 Sep 15 | 19,854 | 350 | 1,827 | 0 |
| 30 Jun 15 | 18,548 | 339 | 1,699 | 0 |
| 31 Mar 15 | 17,102 | 298 | 1,564 | 0 |
| 31 Dec 14 | 15,689 | 268 | 1,424 | 0 |
| 30 Sep 14 | 14,134 | 210 | 1,300 | 0 |
| 30 Jun 14 | 12,700 | 179 | 1,183 | 0 |
| 31 Mar 14 | 11,475 | 172 | 1,055 | 0 |
| 31 Dec 13 | 10,544 | 161 | 931 | 0 |
Des revenus de qualité: CNC a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de CNC sont plus élevées que l'année dernière CNC. (2.1%) sont plus élevées que l'année dernière (1.8%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de CNC ont augmenté de 17.3% par an au cours des 5 dernières années.
Accélération de la croissance: La croissance des bénéfices de CNC au cours de l'année écoulée ( 25.5% ) dépasse sa moyenne sur 5 ans ( 17.3% par an).
Bénéfices par rapport au secteur d'activité: La croissance des bénéfices CNC au cours de l'année écoulée ( 25.5% ) a dépassé celle du secteur Healthcare 10.3%.
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de CNC ( 11.1% ) est considéré comme faible.